Leash Bio Revenue and Competitors
Employee Data
- Leash Bio has 14 Employees.
- Leash Bio grew their employee count by 75% last year.
Leash Bio's People
Name | Title | Email/Phone |
---|
Leash Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.8M | 4 | 0% | N/A | N/A |
#2 | N/A | 15 | 67% | N/A | N/A |
#3 | $1.4M | 7 | 0% | N/A | N/A |
#4 | $5.9M | 38 | 41% | N/A | N/A |
#5 | $1.1M | 7 | -53% | N/A | N/A |
#6 | $1.6M | 7 | -12% | N/A | N/A |
#7 | $21.2M | 137 | 10% | N/A | N/A |
#8 | $1.6M | 33 | -48% | $17.8M | N/A |
#9 | $1.9M | 18 | 80% | N/A | N/A |
#10 | $3.7M | 11 | 0% | N/A | N/A |
What Is Leash Bio?
Every single machine learning (ML)-driven breakthrough, from language translation to Go championships, was immediately preceded not by an algorithmic innovation but by a massive, well-controlled, purpose-built dataset. An ML-driven breakthrough in medicinal chemistry is going to require a similar dataset, but such high-quality, well-structured experimental data doesn’t exist yet. We're building that data set by making physical measurements of lots of targets (with automated in-house protein production) screened against lots of compounds (with DNA-encoded chemical libraries). We're also building the ML models, that will eventually be generalizable across any protein and novel medicines using insights from our models.
keywords:N/AN/A
Total Funding
14
Number of Employees
N/A
Revenue (est)
75%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 14 | 8% | N/A |
#2 | $1.2M | 14 | 8% | N/A |
#3 | $1.9M | 14 | 0% | N/A |
#4 | $1.7M | 14 | 17% | N/A |
#5 | $1.2M | 14 | -18% | N/A |